North Staffordshire Joint Formulary
North Staffordshire Clinical Commissioning Group
Stoke-on-Trent Clinical Commissioning Group

 
back
4 Central nervous system
04-10-02 Nicotine dependence

Everyone Health, the service provider for smoking cessation service confirms it is now open to all tobacco smokers, living anywhere in Staffordshire, aged 40 years and over. Referrals can still be made by calling the contact centre on 0333 005 0095, or via email: eh.staffs@nhs.net

Link to website - everyonehealth.co.uk


Nicotine replacement therapy
First Choice

1st line for smoking cessation.

Restriction: As part of a smoking cessation programme or during inpatient stay only.

Nicotine replacement therapy is funded by Public Health. GPs should not routinely prescribe; patients should be directed to a local provider of stop smoking services to access support and treatment.

Self Care Self Care Medicine-Available OTC for self-care.

 


Green View adult BNF  View SPC online  View childrens BNF
Bupropion hydrochloride Zyban®
Second Choice

Bupropion HCl Tablet 150mg M/R

2nd line for smoking cessation.

Restriction: As part of a smoking cessation programme only.

APC Advice: Varenicline (Champix®), revised May 2008.

  • Nicotine Replacement Therapy remains the pharmacological agent of choice for smoking cessation.
  • Consider varenicline or bupropion if NRT ineffective, not tolerated or inappropriate.
  • Only use as a component of a smoking cessation programme. 
  • Current evidence is insufficient to recommend an additional treatment course in those who have stopped smoking after the initial 12 weeks of therapy

MHRA/CHM advice: Bupropion (Zyban®): risk of serotonin syndrome with use with other serotonergic drugs (November 2020)


Green View adult BNF  View SPC online  View childrens BNF
Varenicline Champix®
Second Choice

Varenicline Tartrate Tablet 0.5mg 
Varenicline Tartrate Tablet 1mg
Varenicline Starter Pack (11 x 500mcg Tabs + 14 x 1mg Tabs)

2nd line for smoking cessation.

Restriction: As part of a smoking cessation programme only.

APC Advice: Varenicline (Champix®), revised May 2008.

  • Nicotine Replacement Therapy remains the pharmacological agent of choice for smoking cessation.
  • Consider varenicline or bupropion if NRT ineffective, not tolerated or inappropriate.
  • Only use as a component of a smoking cessation programme. 
  • Current evidence is insufficient to recommend an additional treatment course in those who have stopped smoking after the initial 12 weeks of therapy
Link  NICE TA123: Varenicline
 

Green View adult BNF  View SPC online  View childrens BNF